{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:27:09Z","timestamp":1780352829066,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.medcli.2020.02.006","type":"journal-article","created":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T20:10:04Z","timestamp":1589746204000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Association between benzodiazepine use and development of dementia"],"prefix":"10.1016","volume":"156","author":[{"given":"Pablo","family":"Aldaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garj\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Beitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idoya","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Librero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma Jos\u00e9","family":"Ariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2020.02.006_bib0150","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/pds.4551","article-title":"Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: a national register study for 2006 to 2014","volume":"27","author":"Kurko","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.medcli.2020.02.006_bib0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.medcli.2020.02.006_bib0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4321\/S1135-57272013000300004","article-title":"Evoluci\u00f3n del uso de medicamentos ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a durante el per\u00edodo 2000\u20132011","volume":"87","author":"Vicente S\u00e1nchez","year":"2013","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"10.1016\/j.medcli.2020.02.006_bib0165","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Secretar\u00eda de Estado de Servicios Sociales e Igualdad. Delegaci\u00f3n del Gobierno para el Plan Nacional sobre Droga. Encuesta sobre alcohol y drogas en poblaci\u00f3n general en Espa\u00f1a: EDADES 2011\u20132012; 2013. Available from: http:\/\/www.pnsd.msc.es\/Categoria2\/observa\/pdf\/EDADES2011.pdf [accessed 12.12.18]."},{"key":"10.1016\/j.medcli.2020.02.006_bib0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.archger.2016.09.003","article-title":"Inappropriate prescribing in older persons: a systematic review of medications available in different criteria","volume":"68","author":"Lucchetti","year":"2017","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.medcli.2020.02.006_bib0175","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence and usage patterns \u2013 a systematic review of register-based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.medcli.2020.02.006_bib0180","first-page":"111","article-title":"Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment","volume":"58","author":"Smith","year":"2001","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.medcli.2020.02.006_bib0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jsmc.2018.03.001","article-title":"Prescription drugs used in insomnia","volume":"13","author":"Dujardin","year":"2018","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.medcli.2020.02.006_bib0190","first-page":"CD011481","article-title":"Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users","volume":"3","author":"Baandrup","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medcli.2020.02.006_bib0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.medcli.2020.02.006_bib0200","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.arcmed.2012.11.003","article-title":"Epidemiology of dementias and Alzheimer's disease","volume":"43","author":"Sosa-Ortiz","year":"2012","journal-title":"Arch Med Res"},{"key":"10.1016\/j.medcli.2020.02.006_bib0205","doi-asserted-by":"crossref","DOI":"10.1002\/phar.2170","article-title":"Association between development of dementia and use of benzodiazepines: a systematic review and meta-analysis","author":"Lucchetta","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.medcli.2020.02.006_bib0210","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: prospective population based study","volume":"345","author":"Billioti de Gage","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2020.02.006_bib0215","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jech-2011-200314","article-title":"Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)","volume":"66","author":"Gallacher","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.medcli.2020.02.006_bib0220","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: a population-based cohort study","volume":"12","author":"Shash","year":"2016","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.medcli.2020.02.006_bib0225","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer's disease: case\u2013control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2020.02.006_bib0230","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/JGP.0b013e3181e049ca","article-title":"Effect of benzodiazepine discontinuation on dementia risk","volume":"19","author":"Wu","year":"2011","journal-title":"Am J Geriatric Psychiatry"},{"key":"10.1016\/j.medcli.2020.02.006_bib0235","doi-asserted-by":"crossref","DOI":"10.1111\/acps.12909","article-title":"The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case\u2013control study","author":"Tapiainen","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.medcli.2020.02.006_bib0240","doi-asserted-by":"crossref","unstructured":"Zhong G, Wang Y, Zhang Y, Zhao Y. Association between benzodiazepine use and dementia: a meta-analysis. PLoS ONE 10:e0127836. http:\/\/dx.doi.org\/10.1371\/journal.pone.0127836.","DOI":"10.1371\/journal.pone.0127836"},{"key":"10.1016\/j.medcli.2020.02.006_bib0245","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7150\/ijms.16185","article-title":"Association between benzodiazepine use and dementia: data mining of different medical databases","volume":"13","author":"Takada","year":"2016","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.medcli.2020.02.006_bib0250","doi-asserted-by":"crossref","unstructured":"Imfeld P, Bodmer M, Jick SS, Meier CR. Benzodiazepine use and risk of developing Alzheimer's disease or vascular dementia: a case\u2013control analysis. Drug Saf [Internet]. 2015;38:909\u201319. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26123874 [cited 28.09.16].","DOI":"10.1007\/s40264-015-0319-3"},{"key":"10.1016\/j.medcli.2020.02.006_bib0255","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-151006","article-title":"Regular benzodiazepine and Z-substance use and risk of dementia: an analysis of German claims data","volume":"54","author":"Gomm","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.medcli.2020.02.006_bib0260","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: a population-based cohort study","volume":"12","author":"Shash","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.medcli.2020.02.006_bib0265","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/JGP.0b013e3181a65210","article-title":"The association between dementia and long-term use of benzodiazepine in the elderly: nested case\u2013control study using claims data","volume":"17","author":"Wu","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.medcli.2020.02.006_bib0270","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.2146\/ajhp160381","article-title":"Benzodiazepine use and cognitive decline in the elderly","volume":"75","author":"Picton","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.medcli.2020.02.006_bib0275","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2020.02.006_bib0280","doi-asserted-by":"crossref","DOI":"10.1177\/1533317514524813","article-title":"Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials","author":"Tampi","year":"2014","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.medcli.2020.02.006_bib0285","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/0891988709335794","article-title":"Consistency of clinical diagnosis of dementia in NEDICES: a populationbased longitudinal study in Spain","volume":"22","author":"Bermejo-Pareja","year":"2009","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.medcli.2020.02.006_bib0290","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.3399\/bjgp16X683485","article-title":"Efficacy of two interventions on the discontinuation of benzodiazepines in long-term users: 36-month follow-up of a cluster randomised trial in primary care","volume":"66","author":"Vicens","year":"2016","journal-title":"Br J Gen Pract"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320301913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775320301913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T20:24:51Z","timestamp":1611433491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775320301913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0025775320301913"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2020.02.006","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between benzodiazepine use and development of dementia","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2020.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}